在使用Kratom后,严重的黄与危及生命的肝衰竭:通过血交换逆转
1Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA.
概括
这个案例研究探讨了Kratom的毒性,一个潜在的致命的草药补充剂. 研究人员报告称,使用血交换成功治疗严重的肝损伤,这是对Kratom中毒的一种新方法.
科学领域:
- 毒理学 毒理学 毒理学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 克拉 (Mitragyna speciosa) 是一种具有刺激和止痛功能的草药补充剂,作用于阿片类受体.
- Kratom 使用与潜在的毒性有关,包括肝损伤,过量服用可能是致命的.
- 目前没有针对Kratom毒性的特定解药,治疗依赖于支持性护理.
研究的目的:
- 报告首次使用血交换作为严重的Kratom诱导肝损伤的非传统疗法.
- 评估血交换在逆转Kratom毒性的临床和生化表现方面的疗效.
主要方法:
- 一名56岁的男性患者出现了严重的黄和肝功能衰竭,这归因于Kratom的使用.
- 广泛的检查排除了肝损伤的其他原因,例如肝脏质量.
- 血交换是在获得患者同意后作为试验性治疗开始的.
主要成果:
- 经过四次血交换手术后,患者的胆红素总水平显著下降,从70.6 mg/dL降至23.9 mg/dL.
- 患者经历了显著的临床改善,并在第五天出院,总 bilirubin 为 21.3 mg/dL.
- 没有报告与血交换程序相关的不良事件.
结论:
- 血交换似乎是一种安全有效的方法来逆转由Kratom毒性引起的严重肝损伤.
- 这一案例凸显了血交换作为一种新的治疗策略的潜力,用于在支持性护理不足时管理Kratom过量服用.
- 需要进一步的研究来确认血交换在Kratom中毒中的作用并优化血交换的应用.
相关概念视频
Prevention of Further Absorption of Poison
821
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
821
Enhanced Elimination of Poison
511
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
511
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Drug Elimination: Non-Renal Routes
2.3K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.3K


